Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Active, Not Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06846398 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Shanghai Argo Biopharmaceutical Co., Ltd. |
| Last Updated on CT.gov | April 17, 2026 (Yesterday) |
As of April 18, 2026: Clinical trial NCT06846398 is currently active_not_recruiting participants. This clinical trial study for hereditary angioedema is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Shanghai Argo Biopharmaceutical Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06846398 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06846398 was last updated Yesterday (April 17, 2026). HelloStudys verifies this status automatically.